IP Library Assignment 067203/0686
Patent Assignment
Reel/Frame 067203/0686

Assignment of Assignor's Interest

Recorded: 2024-04-23 Pages: 13
Assignor
PAR PHARMACEUTICAL, INC.
Executed: 2024-04-23
Assignee
ENDO USA, INC.
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
Covered Properties (43)
Nasal Calcitonin Formulations Containing Chlorobutanol
Patent: 7,812,120 →
Application: 10/805,788 →
Publication: US 2004/0224890
System and Method for Sorting Data
Patent: 7,246,020 →
Application: 11/150,614 →
Publication: US 2006/0293863
Nasal Calcitonin Formulations Containing Chlorobutanol
Patent: 8,138,149 →
Application: 12/878,936 →
Publication: US 2011/0009321
Nasal Calcitonin Formulations Containing Chlorobutanol
Patent: 8,486,891 →
Application: 13/371,037 →
Publication: US 2012/0142592
Epinephrine Formulations
Patent: 9,119,876 →
Application: 14/657,990 →
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,744,239 →
Application: 14/717,877 →
Publication: US 2016/0220676
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,375,478 →
Application: 14/717,882 →
Epinephrine Formulations
Patent: 9,295,657 →
Application: 14/818,121 →
Epinephrine Formulations
Application: 14/863,112 →
Publication: US 2016/0263059
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,687,526 →
Application: 15/289,640 →
Publication: US 2017/0035853
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,744,209 →
Application: 15/426,693 →
Publication: US 2017/0157202
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,750,785 →
Application: 15/426,703 →
Publication: US 2017/0157203
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,937,223 →
Application: 15/606,442 →
Publication: US 2017/0290880
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,925,233 →
Application: 15/612,649 →
Publication: US 2017/0290881
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,981,006 →
Application: 15/688,305 →
Publication: US 2018/0000888
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,962,422 →
Application: 15/688,314 →
Publication: US 2018/0000889
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,974,827 →
Application: 15/688,322 →
Publication: US 2017/0360876
Vasopressin Formulations for Use in Treatment of Hypotension
Application: 15/688,326 →
Publication: US 2018/0000890
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,925,234 →
Application: 15/688,330 →
Publication: US 2017/0360877
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,993,520 →
Application: 15/688,334 →
Publication: US 2018/0000891
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,968,649 →
Application: 15/688,336 →
Publication: US 2017/0360878
Vasopressin Formulations for Use in Treatment of Hypotension
Patent: 9,919,026 →
Application: 15/688,338 →
Publication: US 2018/0015140
Epinephrine Formulations
Application: 16/258,204 →
Publication: US 2019/0151261
Vasopressin Formulations for Use in Treatment of Hypotension
Application: 16/291,796 →
Publication: US 2019/0192615
Vasopressin Formulations for Use in Treatment of Hypotension
Application: 16/291,915 →
Publication: US 2019/0192616
Epinephrine Formulations
Application: 16/817,253 →
Publication: US 2020/0206163
Pre-Filled Syringe Containing Sugammadex
Application: 16/919,790 →
Method to Treat Hypotension Using Vasopressin in Certain Genotypes
Application: 16/932,351 →
Method to Treat Hypotension Using Vasopressin in Certain Genotypes
Application: 17/070,103 →
Peptide Congeners with Polymer Excipients
Application: 17/104,102 →
Publication: US 2021/0077568
Collagenase Formulations and Methods of Producing the Same
Application: 17/419,899 →
Publication: US 2022/0305094
Vasopressin Formulations for Use in Treatment of Hypotension
Application: 17/472,393 →
Publication: US 2022/0133838
Epinephrine Formulations
Application: 17/685,090 →
Publication: US 2023/0100523
Epinephrine Formulations
Application: 17/694,165 →
Publication: US 2023/0285326
Varenicline Compound and Process of Manufacture Thereof
Application: 17/721,857 →
Publication: US 2022/0249508
Vasopressin Formulations for Use in Treatment of Hypotension
Application: 17/861,353 →
Publication: US 2023/0256048
Varenicline Compound and Process of Manufacture Thereof
Application: 17/930,824 →
Varenicline Compound and Process of Manufacture Thereof
Application: 17/930,940 →
Publication: US 2023/0285404
Vareniciline Compound and Process of Manufacture Thereof
Application: 18/148,659 →
Publication: US 2023/0285406
Varenicline Compound and Process of Manufacture Thereof
Application: 18/298,175 →
Publication: US 2023/0285407
Epinephrine Formulations
Application: 18/470,256 →
Publication: US 2024/0091176
Epinephrine Formulations
Application: 18/477,161 →
Publication: US 2024/0058281
Varenicline Compound and Process of Manufacture Thereof
Application: 63/319,043 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 26, 2016
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICALS, INC.
Reel/Frame 040491/0176 →
Assignment of Assignor's Interest Mar 2, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 041442/0453 →
Assignment of Assignor's Interest Mar 2, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 041442/0482 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 040491 Frame 0176. Assignor(S) Hereby Confirms the Patent Assignment. Apr 19, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 042097/0331 →
Corrective Assignment to Correct the Typographical Error of the Receiving Party on the Patent Assignment Cover Sheet Previously Recorded at Reel: 040491 Frame: 0176. Assignor(S) Hereby Confirms the Assignment. Apr 20, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 042293/0855 →
Release of Security Interest Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: PAR PHARMACEUTICAL, INC.; ENDO GENERICS HOLDINGS, INC.; INNOTEQ, INC.
Reel/Frame 042171/0036 →
Security Interest Jun 8, 2017
From: PAR PHARMACEUTICAL, INC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0216 →
Assignment of Assignor's Interest Jun 16, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 042734/0088 →
Assignment of Assignor's Interest Jun 16, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 042734/0093 →
Assignment of Assignor's Interest Oct 19, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 043900/0934 →
Assignment of Assignor's Interest Oct 19, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 043900/0948 →
Assignment of Assignor's Interest Oct 19, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 043900/0957 →
Assignment of Assignor's Interest Oct 19, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 043901/0079 →
Confirmatory Grant of Security Interest in United States Patents May 26, 2020
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052752/0269 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0618 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
Confirmatory Grant of Security Interest in United States Patents Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
Release of Security Interest Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0491 →
Release of Security Interest Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0542 →
Release of Security Interest Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
Release of Security Interest Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
Release of Security Interest Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067239/0682 →
Assignment of Assignor's Interest Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
Security Interest Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →